MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
about
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancermiR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights.Noncoding RNAs in endocrine malignancymicroRNA evaluation of unknown primary lesions in the head and neckMolecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis.Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours.Identification of microRNAs that mediate thyroid cell growth induced by TSHDynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.Non-coding RNAs: a key to future personalized molecular therapy?Multicentre validation of a microRNA-based assay for diagnosing indeterminate thyroid nodules utilising fine needle aspirate smears.MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma.In-depth profiling and analysis of host and viral microRNAs in Japanese flounder (Paralichthys olivaceus) infected with megalocytivirus reveal involvement of microRNAs in host-virus interaction in teleost fish.MIR141 Expression Differentiates Hashimoto Thyroiditis from PTC and Benign Thyrocytes in Irish Archival Thyroid Tissues.MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" casesEvaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samplesMolecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate CytologyIntegrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management.miRNA profiling, detection of BRAF V600E mutation and RET-PTC1 translocation in patients from Novosibirsk oblast (Russia) with different types of thyroid tumorsMicroRNAs in thyroid cancer.MicroRNA as a diagnostic tool in fine-needle aspiration biopsy of thyroid nodules.Expression profiling of difficult-to-diagnose thyroid histologic subtypes shows distinct expression profiles and identify candidate diagnostic microRNAsA systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs.MicroRNA expression profiles in differentiated thyroid cancer, a reviewGrowth factor TGF-β induces intestinal epithelial cell (IEC-6) differentiation: miR-146b as a regulatory component in the negative feedback loop.MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.Microrna-199a-5p Functions as a Tumor Suppressor via Suppressing Connective Tissue Growth Factor (CTGF) in Follicular Thyroid CarcinomaExpression of miRNAs in Papillary Thyroid Carcinomas Is Associated with BRAF Mutation and Clinicopathological Features in Chinese Patients.MicroRNA Expression Profiles in Papillary Thyroid Carcinoma, Benign Thyroid Nodules and Healthy Controls.Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinomaPredicting malignancy in thyroid nodules: molecular advances.Value of distinguishing differentiated thyroid carcinoma by miRNA.Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.p21 participates in the regulation of anaplastic thyroid cancer cell proliferation by miR-146b.The evolution of biomarkers in thyroid cancer-from mass screening to a personalized biosignature.Molecular markers of aggressiveness of thyroid cancer.MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancerDiagnostic markers and prognostic factors in thyroid cancer.MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma
P2860
Q30367068-04ECDC80-344C-4C48-A180-F1FC0741B89BQ31145646-B7504FC8-E78C-46EC-8515-2F94EC164791Q33568629-85648174-538F-413F-9667-F3046C28DC65Q33577889-62C7E4CF-5B1B-4A5A-AF97-35C408ED2911Q33592209-0ABC8C18-BDB5-4AD9-9EFD-59D2AA0E2049Q33624558-FF5A67BC-86F4-4567-AE72-67041BA032BFQ33630865-26859FE7-AB24-44F2-A54D-E493AC4D3125Q33636620-6109DEF1-ADDE-45AB-BDAF-7FADDC7DC0DCQ33750895-C90302CA-DB0B-4F31-9076-693B465D003BQ33762263-A93A280B-D443-45D4-9871-52898A3496F4Q33833144-AC5A132B-07D3-4318-A86B-33F8BDE27E47Q34147480-C234E56D-98D3-42D0-95EF-0223E335ABFAQ34354739-3208FCA9-585B-4B38-8F4F-2BC7F36D9724Q34411905-18EF01FE-C7C4-4C65-90A1-75BCA263E91CQ35638826-F42B106A-1721-4B14-B13F-F5816FD8A157Q35778542-69D3F531-D9ED-4D6B-B721-68ED96269FD8Q35813259-C9E9BE29-C799-42B3-AB07-E7C29781D3A8Q35832157-E4CAC404-C37C-4FA1-A66B-E41E2A935A3AQ35845715-E10DF476-F603-4C29-92DA-265C74B5D166Q35951601-6F2895C0-636E-41CD-B22D-AD14CE6C4179Q36134682-60E39E0E-AB2C-4859-B1F2-7AA4738E27ABQ36182811-B92FB6C0-7E10-465E-B755-7C77D52538C0Q36326608-6C4BEC1D-6012-4B42-A03F-7ECE6E4570B2Q36437698-EB69786F-5A2B-4F38-A9A6-88F52BC04527Q36449793-64BFCFB0-21FF-4A18-82B5-B63E7DE1622FQ36502003-85AEAAF5-FFA5-4D2C-BE7B-A5CFDF7EE28FQ36508828-F3472B20-C882-43FE-A50C-C2B97C5748C7Q36794100-10BCC478-CD24-473D-AEC1-F902C9BDF0B5Q36804803-209B6519-1E7F-422F-A95F-05DBD637EE4AQ36882561-FCA18ED1-2B4C-4E34-81C5-54DA3D5D6E3DQ36884764-A28C641E-B062-4342-B522-6D40C87ACF97Q36934675-0FD76ABE-52D2-446A-A224-CDD8E2BD5274Q37001412-96F80589-3032-4CEE-814C-4BDF729371A6Q37032712-D1562261-116F-4C87-B2AA-5EF163D236E8Q37205979-564B654F-7795-4FA5-892B-4D78B2191377Q37328369-CA7C8D80-79A5-4076-9C20-13E8EEDA7021Q37544168-9407E4B6-7917-425B-A754-3C98AE8A8916Q37569512-D557F1C4-9817-4681-ACDC-2F42E4708A0AQ37620399-1B183E03-EFFB-4BEE-B71A-CBA0409C7F9EQ37623563-A6684816-DB9C-4732-A9FD-5ADA6D8FDFDA
P2860
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
@en
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
@nl
type
label
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
@en
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
@nl
prefLabel
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
@en
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
@nl
P2093
P2860
P1433
P1476
MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.
@en
P2093
Naoki Kitabayashi
Theresa Scognamiglio
Thomas J Fahey
Yao-Tseng Chen
P2860
P2888
P304
P356
10.1038/MODPATHOL.2008.105
P577
2008-06-27T00:00:00Z